{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:39:58Z","timestamp":1757450398278},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1984,6,1]],"date-time":"1984-06-01T00:00:00Z","timestamp":454896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1984,6]]},"DOI":"10.1007\/bf01727749","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T00:43:43Z","timestamp":1118623423000},"page":"543-548","source":"Crossref","is-referenced-by-count":22,"title":["The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophilia"],"prefix":"10.1007","volume":"62","author":[{"given":"M.","family":"K\u00f6hler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hellstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Blohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01727749_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","volume":"56","author":"CF Abildgaard","year":"1980","unstructured":"Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS (1980) Serial studies in von Willebrand's disease: Variability versus \u201cvariants\u201d. Blood 56:712\u2013716","journal-title":"Blood"},{"key":"BF01727749_CR2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.1980.tb05995.x","volume":"46","author":"TW Barrowcliffe","year":"1980","unstructured":"Barrowcliffe TW, Kirkwood TBL (1980) Standardization of factor VIII. I. Calibration of British standards for factor VIII clotting activity. Br J Haematol 46:471\u2013481","journal-title":"Br J Haematol"},{"key":"BF01727749_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01716807","volume":"60","author":"M Barthels","year":"1982","unstructured":"Barthels M, Edel J, Liese B, Karges HE (1982) Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome. Klin Wochenschr 60:303\u2013309","journal-title":"Klin Wochenschr"},{"key":"BF01727749_CR4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0038-1657144","volume":"47","author":"JJF Belch","year":"1982","unstructured":"Belch JJF, Small M, McKenzie F, Hill PA, Lowe GDO, McIntyre DE, Forbes CD, Prentice CRM (1982) DDAVP stimulates prostacyclin production. Thromb Haemostas 47:122\u2013123","journal-title":"Thromb Haemostas"},{"key":"BF01727749_CR5","first-page":"1367","volume":"109","author":"W Bl\u00e4ttler","year":"1979","unstructured":"Bl\u00e4ttler W, Jacky E, M\u00fcller M, Graf M (1979) Der Einflu\u00df von 1-Desamino-8-Arginin-Vasopressin (DDAVP) auf die Blutgerinnung bei Patienten mit H\u00e4mophilia A und gesunden M\u00e4nnern. Schweiz med Wochenschr 109:1367\u20131368","journal-title":"Schweiz med Wochenschr"},{"key":"BF01727749_CR6","unstructured":"Bundesverband der Pharmazeutischen Industrie e.V. (1982) Rote Liste 6000 Frankfurt a.M. EDITIO Cantor. Aulendorf\/W\u00fcrttemberg"},{"key":"BF01727749_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","volume":"17","author":"A Clauss","year":"1957","unstructured":"Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17:237\u2013246","journal-title":"Acta Haematol"},{"key":"BF01727749_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(76)92967-6","volume":"2","author":"AD Cramer","year":"1976","unstructured":"Cramer AD, Melaragno AJ, Phifer SJ, Hougie C (1976) Von Willebrand disease San Diego, a new variant. Lancet 2:12\u201314","journal-title":"Lancet"},{"key":"BF01727749_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0038-1657320","volume":"49","author":"A D'Angelo","year":"1983","unstructured":"D'Angelo A, Capitanio A, Smith JB, Valsecchi C, Manucci PM (1983) Effect of Des-Amino-D-Arginine Vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. Thromb Haemostas 49:64","journal-title":"Thromb Haemostas"},{"key":"BF01727749_CR10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2141.1983.tb02856.x","volume":"55","author":"G Gamba","year":"1983","unstructured":"Gamba G, Grignani G, Longoni P, Ascari E (1983) Response of factor XII to DDAVP in patients with Hageman factor deficiency. Br J Haematol 55:713\u2013715","journal-title":"Br J Haematol"},{"key":"BF01727749_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0038-1657224","volume":"48","author":"VV Garcia","year":"1982","unstructured":"Garcia VV, Silva IA, Borrasca AL (1982) Response of factor VIII\/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII). Thromb Haemostas 48:91\u201393","journal-title":"Thromb Haemostas"},{"key":"BF01727749_CR12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0038-1657291","volume":"48","author":"P Hellstern","year":"1982","unstructured":"Hellstern P, Miyashita C, K\u00f6hler M, Wenzel E, Holl W (1982) Thrombin-induced platelet malondialdehyde (MDA) formation in normal subjects and in women taking oral contraceptives. Thromb Haemostas 48:325\u2013326","journal-title":"Thromb Haemostas"},{"key":"BF01727749_CR13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0049-3848(79)90220-2","volume":"16","author":"I Kobayashi","year":"1979","unstructured":"Kobayashi I (1979) Treatment of hemophilia A and von Willebrand's disease patients with an intranasal dripping of DDAVP. Thromb Res 16:775\u2013779","journal-title":"Thromb Res"},{"key":"BF01727749_CR14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(77)91469-6","volume":"2","author":"G Lowe","year":"1977","unstructured":"Lowe G, Pettigrew A, Middleton S, Forbes CD, Prentice CRM (1977) D.D.A.V.P. in haemophilia. Lancet 2:614\u2013615","journal-title":"Lancet"},{"key":"BF01727749_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2141.1980.tb07169.x","volume":"45","author":"CA Ludlam","year":"1980","unstructured":"Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA, Bloom AL (1980) Factor VIII and fibrinolytic response to deamino-8-D-arginine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Br J Haematol 45:499\u2013511","journal-title":"Br J Haematol"},{"key":"BF01727749_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0038-1651343","volume":"34","author":"DE MacFarlane","year":"1975","unstructured":"MacFarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPerson J (1975) A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diathes Haemorrh 34:306\u2013307","journal-title":"Thromb Diathes Haemorrh"},{"key":"BF01727749_CR17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","volume":"2","author":"PM Manucci","year":"1977","unstructured":"Manucci PM, Ruggeri ZM, Pareti FI, Capitanio A (1977a) 1-deamino-8-D-arginine vasopressin: A new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 2:869\u2013872","journal-title":"Lancet"},{"key":"BF01727749_CR18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(77)91555-0","volume":"1","author":"PM Manucci","year":"1977","unstructured":"Manucci PM, Ruggeri ZM, Paveti FI, Capitanio A (1977b) D.D.A.V.P. in haemophilia. Lancet 1:1171\u20131172","journal-title":"Lancet"},{"key":"BF01727749_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","volume":"47","author":"PM Manucci","year":"1981","unstructured":"Manucci PM, Canciani MT, Rota L, Donovan BS (1981) Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects and patients with hemophilia A and von Willebrand's disease. Br J Haematol 47:283\u2013293","journal-title":"Br J Haematol"},{"key":"BF01727749_CR20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V34.2.204.204","volume":"34","author":"CH Mielke","year":"1969","unstructured":"Mielke CH, Kaneshiro MM, Maher IA, Weiner JM Rapaport SI (1969) The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34:204\u2013215","journal-title":"Blood"},{"key":"BF01727749_CR21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.1983.tb02124.x","volume":"54","author":"GG Nenci","year":"1983","unstructured":"Nenci GG, Berrettini M, DeCunto M, Agnelli G (1983) Effect of DDAVP on plasma level of factor XII. Br J Haematol 54:489\u2013492","journal-title":"Br J Haematol"},{"key":"BF01727749_CR22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0038-1646712","volume":"39","author":"IM Nilsson","year":"1978","unstructured":"Nilsson IM (1978) Report of the working party on factor VIII-related antigens. Thromb Haemostas 39:511\u2013520","journal-title":"Thromb Haemostas"},{"key":"BF01727749_CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0609.1980.tb02749.x","volume":"24","author":"IM Nilsson","year":"1980","unstructured":"Nilsson IM, Holmberg L, Aberg M, Vilhardt H (1980) The release of plasminogen activator and factor VIII after injection of DDAVP in healthy volunteers and in patients with von Willebrand's disease. Scand J Haematol 24:351\u2013359","journal-title":"Scand J Haematol"},{"key":"BF01727749_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0609.1982.tb00565.x","volume":"29","author":"IM Nilsson","year":"1982","unstructured":"Nilsson IM, Mikaelsson M, Vilhardt H (1982) The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons. Scand J Haematol 29:70\u201374","journal-title":"Scand J Haematol"},{"key":"BF01727749_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1423-0410.1981.tb01025.x","volume":"41","author":"G Norkrans","year":"1981","unstructured":"Norkrans G, Widell A, Teger-Nilsson AC, Kjellman H, Fr\u00f6sner G, Iwarson S (1981) Acute hepatitis non-A, non-B following administration of factor VIII concentrates. Vox Sang 41:129\u2013133","journal-title":"Vox Sang"},{"key":"BF01727749_CR26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","volume":"59","author":"ZM Ruggeri","year":"1982","unstructured":"Ruggeri ZM, Manucci PM, Lombardi R, Federici AB, Zimmerman TS (1982) Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP: Implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 59:1272\u20131278","journal-title":"Blood"},{"issue":"Suppl 1","key":"BF01727749_CR27","first-page":"185","volume":"10","author":"K Schimpf","year":"1981","unstructured":"Schimpf K, Niederberger M (1981) Cost effectiveness in treatment of severe hemophilia. Haemostasis 10 (Suppl 1): 185\u2013187","journal-title":"Haemostasis"},{"key":"BF01727749_CR28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJM198203113061004","volume":"10","author":"PS Smith","year":"1982","unstructured":"Smith PS, Keyes NC, Forman EN (1982) Socioeconomic evaluation of a state-funded comprehensive hemophiliacare program. N Engl J Med 10:575\u2013579","journal-title":"N Engl J Med"},{"key":"BF01727749_CR29","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1055\/s-0028-1105576","volume":"102","author":"W Theiss","year":"1977","unstructured":"Theiss W, Sauer E (1977) DDAVP: Alternative zur Substitutionsbehandlung bei leichter H\u00e4mophilie A und von-Willebrand-J\u00fcrgens-Syndrom. Dtsch Med Wochenschr 102:1769\u20131772","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01727749_CR30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3476(83)80526-5","volume":"102","author":"AI Warrier","year":"1983","unstructured":"Warrier AI, Lusher JM (1983) DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand disease. J Pediatr 102:228\u2013233","journal-title":"J Pediatr"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01727749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01727749\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01727749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:55:55Z","timestamp":1586282155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01727749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,6]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1984,6]]}},"alternative-id":["BF01727749"],"URL":"https:\/\/doi.org\/10.1007\/bf01727749","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,6]]}}}